Lancol

Lancol is a pharmaceutical preparation used in some countries, primarily Russia and Ukraine, as a nootropic agent. It is often marketed to improve cognitive functions such as memory, concentration, and learning ability. The active ingredient in Lancol is the peptide complex AC-13, which is derived from the brains of young cattle.

The proposed mechanism of action for Lancol is that the peptides it contains can cross the blood-brain barrier and exert a restorative effect on brain cells. It is believed to promote neurogenesis and improve neuronal communication. Lancol is typically administered orally in tablet form.

Clinical studies on Lancol have been conducted, primarily in Eastern Europe, and some of these studies have reported positive effects on cognitive performance and neurological disorders. However, the quality and methodology of these studies are often debated, and independent, large-scale, placebo-controlled trials in Western medical literature are scarce.

As with any medication, Lancol may have potential side effects. These can include allergic reactions, digestive issues, and in rare cases, central nervous system disturbances. The use of Lancol is generally not recommended for pregnant or breastfeeding women, or individuals with known hypersensitivity to its components. Due to its limited availability and the nature of the supporting research, Lancol is not approved or widely used in Western countries.